
簡要描述:Tirofiban hydrochloride monohydrate 150915-40-5Tirofiban hydrochloride monohydrate is a potent non-peptide, glycoprotein IIb/IIIa (integrins alphaIIbbetaIII) antagonist
產(chǎn)品分類
Product Category詳細(xì)介紹
| 品牌 | absin | CAS | 150915-40-5 |
|---|---|---|---|
| 分子式 | C22H39ClN2O6S | 純度 | >98% |
| 分子量 | 495.07 | 貨號 | abs47028073 |
| 規(guī)格 | 5mg | 供貨周期 | 現(xiàn)貨 |
| 主要用途 | is a potent non-peptide | 應(yīng)用領(lǐng)域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
Tirofiban hydrochloride monohydrate 150915-40-5
| 產(chǎn)品描述 | |
| 描述 | Tirofiban hydrochloride monohydrate is a potent non-peptide, glycoprotein IIb/IIIa (integrins alphaIIbbetaIII) antagonist |
| 純度 | >98% |
| 儲存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | 鹽suan替羅非班水合物 |
| 外觀 | 白色至類白色粉末 |
| 可溶性/溶解性 | DMSO : 12 mg/mL (24.24 mM; Need ultrasonic and warming) |
| 生物活性 | |
| 靶點 | GPIIb/IIIa |
| In vitro(體外研究) | Tirofiban (MK-383, Aggrastat) is a nonpeptide derivative of tyrosine that selectively inhibits the GP-IIb/IIIa receptor, with minimal effects on the ɑvβ3 vitronectin receptor. It inhibits platelet aggregation of gel-filtered platelets induced by 10 μM ADP with IC50 of 9 nM, but the IC50 for inhibition of human umbilical vein adhesion to vitronectin, which depends on ɑvβ3 vitronectin receptors, is 62 μmol/L. |
| In vivo(體內(nèi)研究) | Tirofiban Hydrochloride (10 to 500 mg/kg or 360-min continuous i.v. infusions of 1 to 10 micrograms/kg/min) inhibits platelet aggregation responses to ADP and collagen in canine models. When administered to humans at 0.15μg/kg/min for 4 h, Tirofiban produced a 2.5-fold increase in bleeding time and 97% inhibition of ADP-induced platelet aggregation. |
| 參考文獻(xiàn) | |
| 參考文獻(xiàn) |
|
| 研究領(lǐng)域 | |
| 研究領(lǐng)域 | Signal TransductionCytoskeleton / ECMCytoskeleton Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產(chǎn)品咨詢
